Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. Now the FDA has ...
"Full Measure" host Sharyl Attkisson speaks with Liz Moughon from investigative nonprofit ProPublica about safety concerns related to CPAP breathing machines. SHARYL ATTKISSON: Millions of people rely ...
GLP-1 drugs pose an existential threat to CPAP-makers. ResMed is currently experiencing temporary tailwinds before potential long-term headwinds. ResMed (NYSE: RMD) finds itself in an investment limbo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback